Cognetivity Neurosciences Ltd. CGNSF
Set alert
0.00 USD 0.00 0.00%
At close · Oct 30
0.0019 Day range 0.0019
0.0001 52-week range 0.0019
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.0019
- Prev close
- 0.0001
- Mkt cap
- 8.96K
- Vol
- 1.00K
- Avg vol
- 0
- EPS
- -0.06
- P/E
- 0.00
More statistics
- Low
- 0.0019
- High
- 0.0019
2Y chart
Signals (21)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Apr 24, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 15, 2025 | 1 year ago |
| RSI: Oversold | Apr 14, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 7, 2025 | 1 year ago |
| SMA: Bearish | Mar 13, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 13, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 24, 2025 | 1 year ago |
| SMA: Bullish | Feb 19, 2025 | 1 year ago |
| SMA: Bearish | Feb 14, 2025 | 1 year ago |
| SMA: Bullish | Feb 12, 2025 | 1 year ago |
| SMA: Bearish | Feb 10, 2025 | 1 year ago |
| SMA: Bullish | Feb 5, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 4, 2025 | 1 year ago |
| SMA: Bearish | Feb 3, 2025 | 1 year ago |
| RSI: Overbought | Jan 23, 2025 | 1 year ago |
| SMA: Bullish | Jan 17, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 16, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 10, 2025 | 1 year ago |
| MACD: Buy Signal | Dec 30, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 26, 2024 | 1 year ago |
| MACD: Buy Signal | Dec 20, 2024 | 1 year ago |
News
- CSE Bulletin: Delist - Cognetivity Neurosciences Ltd. (CGN)
- CognICA(TM) Shown to Save Tens of Millions of Dollars in Healthcare Costs Annually and Improve Patient Outcomes in the UK National Health Service
- Cognetivity Neurosciences and UC Health Partner to Improve Early Detection of Cognitive Impairment in USA
- Cognetivity Neurosciences Announces Commercial Agreement with Mediclinic to Provide Cognitive Assessment to Over 50s
- Cognetivity Neurosciences Partners with No Fear Counselling to Pioneer Brain Health Assessment Through Groundbreaking AI Technology
- Cognetivity Neurosciences' AI Powered CognICA Platform Wins Major Industry Award
- Cognetivity Neurosciences' AI Powered CognICA Platform Shortlisted for Major Industry Award
- Cognetivity Neurosciences Announces Publication of Peer-Reviewed Article Showing Effectiveness of its AI Powered CognICA Technology in Detecting Early-Stage Alzheimer's Disease
- Cognetivity Neurosciences Announces Successful Registration With Health Canada for Clinical use of CognICA(TM) AI-Powered Brain Health Technology in Canada
- New Disease Modifying Drug for Alzheimer's Disease Fully Approved by FDA, Highlighting the Crucial Role for Cognetivity in Early Detection and Monitoring
Your note
Sign in to keep a note on CGNSF — it syncs with the Stock Master app.